Drug Repurposing Approach against Novel Coronavirus Disease (COVID-19) through Virtual Screening Targeting SARS-CoV-2 Main Protease
Novel coronavirus disease (COVID-19) was identified from China in December 2019 and spread rapidly through human-to-human transmission, affecting so many people worldwide. Until now, there has been no specific treatment against the disease and repurposing of the drug. Our investigation aimed to scre...
Main Authors: | Kamrul Hasan Chowdhury, Md. Riad Chowdhury, Shafi Mahmud, Abu Montakim Tareq, Nujhat Binte Hanif, Naureen Banu, A. S. M. Ali Reza, Talha Bin Emran, Jesus Simal-Gandara |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | Biology |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-7737/10/1/2 |
Similar Items
-
Virtual Screening of a Library of Naturally Occurring Anthraquinones for Potential Anti-Fouling Agents
by: Gagan Preet, et al.
Published: (2023-01-01) -
Computational Repurposing of Mitoxantrone-Related Structures against Monkeypox Virus: A Molecular Docking and 3D Pharmacophore Study
by: Gagan Preet, et al.
Published: (2022-11-01) -
Identification of potential COVID-19 main protease inhibitors using structure-based pharmacophore approach, molecular docking and repurposing studies
by: Daoud Safa, et al.
Published: (2021-06-01) -
Computational study of nitro-benzylidene phenazine as dengue virus-2 NS2B-NS3 protease inhibitor
by: Nurul Hanim Salin, et al.
Published: (2022-11-01) -
Medication-Wide Association Study Plus (MWAS+): A Proof of Concept Study on Drug Repurposing
by: Yan Cheng, et al.
Published: (2022-08-01)